Integrated Transcriptomic and Functional Analyses Reveal lncRNA ‐ miRNA ‐ mRNA Axis in AML Relapse After Allo‐ HSCT
Cancer Science · 2026-08 · 117 (8) · 2289-2304
DOI: 10.1111/cas.70417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 18.05.2026. Verfasst von Fei Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Hematopoie…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, RNA, Long Noncoding, MicroRNAs, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Tianjin Municipality, Natural Science Foundation of Hebei Province, the Natural Science Foundation of Beijing, China.
Abstract (Originalsprache)
Relapse after allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the leading cause of treatment failure in acute myeloid leukemia (AML), yet the non‐coding RNA‐mediated regulatory mechanisms in relapse‐driving tumor clones are not fully understood. In this study, we performed transcriptomic profiling of CD34 + cells from the bone marrow of patients who had relapsed after allo‐HSCT and from those in sustained remission, and observed that long non‐coding RNAs (lncRNAs) exhibited the largest magnitude of differential expression relative to other RNA classes. To systematically elucidate their function, we integrated correlation analysis, neighborhood topology, and thermodynamic modeling to construct relapse‐associated competing endogenous RNA (ceRNA) networks. These networks highlighted multiple lncRNA‐miRNA‐mRNA axes potentially promoting leukemic progression. Functional interrogation using CRISPR‐based xenograft assays and a single‐cell CRISPR screening platform (Perturb‐seq‐like strategy) revealed that relapse‐associated lncRNAs regulate AML cell proliferation and survival. Among them, SNHG8 emerged as a representative regulator that promotes relapse through the SNHG8‐miR‐625‐ZC3H13/15 signaling axis. SNHG8 knockdown markedly impaired AML cell growth and triggered apoptosis. Furthermore, treatment with hypomethylating agents (HMAs) such as azacitidine and decitabine differentially modulated lncRNA/ceRNA expression signatures, thereby linking clinical interventions to transcriptomic regulation. Together, our findings identify lncRNA‐ceRNA networks in post‐transplant relapse of AML and identify the SNHG8 axis as a potential therapeutic vulnerability, providing a rationale for further investigation of lncRNA‐targeted strategies in this clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Hematopoietic Stem Cell Transplantation Center, Institute of Hematology & Blood…
- Tianjin Institutes of Health Science, Tianjin, P. R. China.
- Haihe Laboratory of Cell Ecosystem, Tianjin Medical University, Tianjin, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), central Laboratory, Peking University Cancer Hospital & Institute, Beijing, P. R. China.
- Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
Förderung
- Natural Science Foundation of Tianjin Municipality
- Natural Science Foundation of Hebei Province
- the Natural Science Foundation of Beijing, China
- Tianjin Municipal Science and Technology Commission Grant
- National Key R&D Program of China
- the National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS)
- National Key Research and Development Program of China
Zitieren
APA
Zhao, F., Wang, W., Gao, H., Zhu, P., Zhai, W., He, Y., Pang, A., Feng, S., Han, M., Wu, L., Qiao, S., Zhang, L., Jiang, E., Pei, X., & Yang, D. (2026). Integrated Transcriptomic and Functional Analyses Reveal lncRNA ‐ miRNA ‐ mRNA Axis in AML Relapse After Allo‐ HSCT. Cancer Science, 117(8), 2289-2304. https://doi.org/10.1111/cas.70417
Vancouver
Zhao F, Wang W, Gao H, Zhu P, Zhai W, He Y, et al. Integrated Transcriptomic and Functional Analyses Reveal lncRNA ‐ miRNA ‐ mRNA Axis in AML Relapse After Allo‐ HSCT. Cancer Science. 2026;117(8):2289-2304. doi:10.1111/cas.70417
BibTeX
@article{Zhao2026,
author = {Zhao, Fei and Wang, Wenhao and Gao, Hongye and Zhu, Ping and Zhai, Weihua and He, Yi and Pang, Aiming and Feng, Sizhou and Han, Mingzhe and Wu, Lina and Qiao, Shukai and Zhang, Lei and Jiang, Erlie and Pei, Xiaolei and Yang, Donglin},
title = {Integrated Transcriptomic and Functional Analyses Reveal lncRNA ‐ miRNA ‐ mRNA Axis in AML Relapse After Allo‐ HSCT},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {8},
pages = {2289--2304},
doi = {10.1111/cas.70417}
}
EUVIMED